The Supreme Court refused to hear a challange to the Prescription Confidentiality Act, which prohibits the sale of prescription information. The First Circuit had upheld the ban on the sale of such information. EPIC and 16 experts in privacy and technology filed a "friend of the court" brief, in support of the law, detailing the substantial privacy interests in de-identified patient data. The petitioners claimed that the law infringed on their free speech rights. See EPIC IMS Health v. Ayotte.
Share this page:
Subscribe to the EPIC Alert
The EPIC Alert is a biweekly newsletter highlighting emerging privacy issues.